Aurora Cannabis Reschedules Fourth Quarter and Full Fiscal Year 2021 Investor Conference Call and Related Year End Informational Filings to Monday, September 27, 2021
Aurora Cannabis Inc. (ACB) has rescheduled its conference call to discuss the fourth quarter and full fiscal year 2021 results to Monday, September 27, 2021, at 5:00 p.m. ET. The financial results and related annual disclosure documents will be released after market close on the same day. CEO Miguel Martin and CFO Glen Ibbott will host the call, allowing investors to submit questions via a designated weblink. Aurora, headquartered in Edmonton, Alberta, is a leader in the cannabis industry, focusing on high-quality cannabis products.
- The rescheduled conference call provides an opportunity for investors to engage directly with leadership.
- The timing aligns with the release of the company's financial results, facilitating transparency.
- There is uncertainty present as the company approaches its results announcement, which may indicate previous performance challenges.
NASDAQ | TSX: ACB
EDMONTON, AB, Sept. 20, 2021 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has rescheduled its conference call to discuss the results for its fourth quarter and full fiscal year 2021 to Monday, September 27, 2021 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report its financial results for the fourth quarter and full fiscal year 2021, and file its related annual disclosure documents, after the close of markets that same day.
New Conference Call Details
DATE: | Monday, September 27, 2021 | |
TIME: | 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time | |
WEBCAST: |
Miguel Martin, Chief Executive Officer, and Glen Ibbott, Chief Financial Officer, will host the conference call and question and answer period. Investors may submit questions in advance or during the conference call through the weblink listed above. This weblink has also been posted to the Company's Investor Relations webpage at https://investor.auroramj.com/ under "News & Events".
About Aurora
Aurora is a global leader in the cannabis industry serving both the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives. The Company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, and Reliva CBD. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, performance, wellness and recreational markets wherever they are launched. For more information, please visit our website at www.auroramj.com.
Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB" and is a constituent of the S&P/TSX Composite Index.
Forward Looking Statements
This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include statements regarding: the timing for reporting of our financial results for the fourth quarter and full fiscal year 2021 and associated conference call. These forward-looking statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward looking statements are based on the opinions, estimates and assumptions of management in light of management's experience and perception of historical trends, current conditions and expected developments at the date the statements are made, such as current and future market conditions, the ability to maintain SG&A costs in line with current expectations, the ability to achieve high margin revenues in the Canadian consumer market, the current and future regulatory environment and future approvals and permits. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements, including the risks associated with: entering the U.S. market, the ability to realize the anticipated benefits associated with the acquisition of Reliva, achievement of Aurora's business transformation plan, general business and economic conditions, changes in laws and regulations, product demand, changes in prices of required commodities, competition, the effects of and responses to the COVID-19 pandemic and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information form dated September 24, 2020 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR at www.sedar.com and filed with and available on the SEC's website at www.edgar.gov. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.
View original content to download multimedia:https://www.prnewswire.com/news-releases/aurora-cannabis-reschedules-fourth-quarter-and-full-fiscal-year-2021-investor-conference-call-and-related-year-end-informational-filings-to-monday-september-27-2021-301380831.html
SOURCE Aurora Cannabis Inc.
FAQ
When will Aurora Cannabis report its fourth quarter and full fiscal year 2021 results?
What time is the Aurora Cannabis investor conference call scheduled?
Who is hosting the Aurora Cannabis conference call?
How can investors submit questions for the Aurora Cannabis conference call?
